These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38784478)

  • 1. Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma.
    Testa JR; Kadariya Y; Friedberg JS
    Oncoscience; 2024; 11():53-57. PubMed ID: 38784478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma.
    Kadariya Y; Sementino E; Shrestha U; Gorman G; White JM; Ross EA; Clapper ML; Neamati N; Miller MS; Testa JR
    Carcinogenesis; 2022 Dec; 43(12):1137-1148. PubMed ID: 36355620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review.
    Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H
    Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
    Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR
    Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
    Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
    J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
    Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
    Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
    Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
    Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort.
    Robinson C; Alfonso H; Woo S; Olsen N; Bill Musk AW; Robinson BW; Nowak AK; Lake RA
    Lung Cancer; 2014 Oct; 86(1):29-34. PubMed ID: 25175318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mesothelioma as an oxidative stress-induced cancer: An update.
    Chew SH; Toyokuni S
    Free Radic Biol Med; 2015 Sep; 86():166-78. PubMed ID: 25975982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma.
    Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H
    Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
    Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
    Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment.
    Kadariya Y; Sementino E; Ruan M; Cheung M; Hadikhani P; Osmanbeyoglu HU; Klein-Szanto AJ; Cai K; Testa JR
    Cancer Res Commun; 2024 Apr; 4(4):1004-1015. PubMed ID: 38592450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.
    Birnie KA; Prêle CM; Thompson PJ; Badrian B; Mutsaers SE
    Oncotarget; 2017 Sep; 8(44):78193-78207. PubMed ID: 29100460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
    Carbone M; Yang H
    Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 protein is a progression factor in malignant pleural mesothelioma.
    Arzt L; Quehenberger F; Halbwedl I; Mairinger T; Popper HH
    Pathol Oncol Res; 2014 Jan; 20(1):145-51. PubMed ID: 23963927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
    Rigon M; Mutti L; Campanella M
    Mol Oncol; 2024 Apr; 18(4):797-814. PubMed ID: 38459714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
    Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR
    Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
    Dragon J; Thompson J; MacPherson M; Shukla A
    J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
    Chew SH; Okazaki Y; Nagai H; Misawa N; Akatsuka S; Yamashita K; Jiang L; Yamashita Y; Noguchi M; Hosoda K; Sekido Y; Takahashi T; Toyokuni S
    Carcinogenesis; 2014 Jan; 35(1):164-72. PubMed ID: 23917077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
    Sneddon S; Leon JS; Dick IM; Cadby G; Olsen N; Brims F; Allcock RJ; Moses EK; Melton PE; de Klerk N; Musk AW; Robinson BW; Creaney J
    Gene; 2015 May; 563(1):103-5. PubMed ID: 25796603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.